Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Hear Res ; 367: 129-136, 2018 09.
Article in English | MEDLINE | ID: mdl-29871827

ABSTRACT

Although there is some data from animal studies, the metabolome of inner ear fluid in humans remains unknown. Characterization of the metabolome of the perilymph would allow for better understanding of its role in auditory function and for identification of biomarkers that might allow prediction of response to therapeutics. There is a major technical challenge due to the small sample of perilymph fluid available for analysis (sub-microliter). The objectives of this study were to develop and validate a methodology for analysis of perilymph metabolome using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Due to the low availability of perilymph fluid; a methodological study was first performed using low volumes (0.8 µL) of cerebrospinal fluid (CSF) and optimized the LC-HRMS parameters using targeted and non-targeted metabolomics approaches. We obtained excellent parameters of reproducibility for about 100 metabolites. This methodology was then used to analyze perilymph fluid using two complementary chromatographic supports: reverse phase (RP-C18) and hydrophilic interaction liquid chromatography (HILIC). Both methods were highly robust and showed their complementarity, thus reinforcing the interest to combine these chromatographic supports. A fingerprinting was obtained from 98 robust metabolites (analytical variability <30%), where amino acids (e.g., asparagine, valine, glutamine, alanine, etc.), carboxylic acids and derivatives (e.g., lactate, carnitine, trigonelline, creatinine, etc.) were observed as first-order signals. This work lays the foundations of a robust analytical workflow for the exploration of the perilymph metabolome dedicated to the research of biomarkers for the diagnosis/prognosis of auditory pathologies.


Subject(s)
Biomarkers/analysis , Chromatography, Reverse-Phase , Hearing Loss, Bilateral/metabolism , Hearing Loss, Sensorineural/metabolism , Metabolomics/methods , Perilymph/chemistry , Spectrometry, Mass, Electrospray Ionization , Adult , Aged , Female , Hearing Loss, Bilateral/diagnosis , Hearing Loss, Bilateral/etiology , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/etiology , Humans , Male , Middle Aged , Reproducibility of Results , Workflow
2.
Audiol Neurootol ; 22(3): 146-153, 2017.
Article in English | MEDLINE | ID: mdl-28982105

ABSTRACT

This study aimed to assess whether lipid-inflammatory-oxidative metabolism influences auditory processing skills, and whether they function in changing auditory performance after hearing aid fitting in the elderly. Twelve subjects with bilateral hearing loss were submitted to blood tests (to check their lipid-inflammatory-oxidative metabolism) and auditory processing skill tests. After 3 months of using the hearing aids, their auditory skills were re-evaluated and the data were correlated statistically. Oxidative stress levels mainly showed some impact on auditory temporal processing; such a relation and others should best be examined in further studies with larger populations.


Subject(s)
Hearing Aids , Hearing Loss, Bilateral/metabolism , Hearing Loss, Sensorineural/metabolism , Lipid Metabolism/physiology , Oxidative Stress/physiology , Speech Perception/physiology , Aged , Female , Hearing Loss, Bilateral/rehabilitation , Hearing Loss, Sensorineural/rehabilitation , Hearing Tests , Humans , Male , Middle Aged
3.
Biochim Biophys Acta Biomembr ; 1859(4): 586-597, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27818172

ABSTRACT

Many years of studies have established that lipids can impact membrane protein structure and function through bulk membrane effects, by direct but transient annular interactions with the bilayer-exposed surface of protein transmembrane domains, and by specific binding to protein sites. Here, we focus on how phosphatidylinositol 4,5-bisphosphate (PIP2) and polyunsaturated fatty acids (PUFAs) impact ion channel function and how the structural details of the interactions of these lipids with ion channels are beginning to emerge. We focus on the Kv7 (KCNQ) subfamily of voltage-gated K+ channels, which are regulated by both PIP2 and PUFAs and play a variety of important roles in human health and disease. This article is part of a Special Issue entitled: Lipid order/lipid defects and lipid-control of protein activity edited by Dirk Schneider.


Subject(s)
Epilepsy, Benign Neonatal/metabolism , Hearing Loss, Bilateral/metabolism , KCNQ1 Potassium Channel/chemistry , Long QT Syndrome/metabolism , Membrane Lipids/chemistry , Amino Acid Sequence , Binding Sites , Cell Membrane/chemistry , Cell Membrane/metabolism , Epilepsy, Benign Neonatal/pathology , Fatty Acids, Unsaturated/chemistry , Fatty Acids, Unsaturated/metabolism , Hearing Loss, Bilateral/pathology , Humans , Hydrophobic and Hydrophilic Interactions , KCNQ1 Potassium Channel/deficiency , KCNQ1 Potassium Channel/metabolism , Long QT Syndrome/pathology , Membrane Lipids/metabolism , Models, Molecular , Phosphatidylinositol 4,5-Diphosphate/chemistry , Phosphatidylinositol 4,5-Diphosphate/metabolism , Protein Binding , Protein Isoforms/chemistry , Protein Isoforms/deficiency , Protein Isoforms/metabolism , Protein Structure, Secondary
4.
Pharmacol Rep ; 67(2): 317-25, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25712657

ABSTRACT

BACKGROUND: Despite that gentamicin is a very effective aminoglycoside, its potential ototoxicity which is of irreversible nature makes a challenge and limitation for its use. This study was designed to investigate possible neurotrophic and antioxidant effects of silymarin comparable to 4-methylcatechol in protection against gentamicin-induced ototoxicity. METHODS AND RESULTS: Twenty pigmented guinea pigs were divided into four equal groups, where group I served as normal control group. The other groups received gentamicin (120 mg/kg/day, ip) for 19 days where group II given vehicle of 1% CMC, group III and group IV were pre-treated 2h before gentamicin by 4-methylcatechol (10 µg/kg, ip) and silymarin (100mg/kg, oral gavage), respectively. The main findings indicated that silymarin exhibited restoration of nerve growth factor (NGF) levels and increased tropomyosin-related kinase receptors-A (Trk-A) m-RNA expression in cochlear tissue and preservation of hair cells of organ of Corti by scanning electron microscopy (SEM) with significant decrease in auditory brainstem response (ABR) threshold compared to 4-methylcatechol. Only silymarin caused significant amelioration in oxidative stress state by reducing malondialdehyde (MDA) levels and increasing catalase activity. CONCLUSIONS: Silymarin exerts superiority over 4-methylcatechol when recommended as protective agent against gentamicin ototoxicity based on its efficient neurotrophic and antioxidant activities.


Subject(s)
Antioxidants/pharmacology , Catechols/pharmacology , Gentamicins/adverse effects , Hearing Loss, Bilateral/chemically induced , Hearing Loss, Bilateral/prevention & control , Neuroprotective Agents/pharmacology , Silymarin/pharmacology , Animals , Cochlea/drug effects , Cochlea/metabolism , Evoked Potentials, Auditory, Brain Stem/drug effects , Evoked Potentials, Auditory, Brain Stem/physiology , Guinea Pigs , Hearing Loss, Bilateral/metabolism , Hearing Loss, Bilateral/physiopathology , Nerve Growth Factor/metabolism , Organ of Corti/drug effects , Organ of Corti/pathology , Organ of Corti/ultrastructure , Oxidative Stress/drug effects , Receptor, trkA
5.
Hear Res ; 224(1-2): 51-60, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17208398

ABSTRACT

Deletions affecting the terminal end of chromosome 3p result in a characteristic set of clinical features termed 3p-- syndrome. Bilateral, sensorineural hearing loss (SNHL) has been found in some but not all cases, suggesting the possibility that it is due to loss of a critical gene in band 3p25. To date, no genetic locus in this region has been shown to cause human hearing loss. However, the ATP2B2 gene is located in 3p25.3, and haploinsufficiency of the mouse homolog results in SNHL with similar severity. We compared auditory test results with fine deletion mapping in seven previously unreported 3p-- syndrome patients and identified a 1.38Mb region in 3p25.3 in which deletions were associated with moderate to severe, bilateral SNHL. This novel hearing loss locus contains 18 genes, including ATP2B2. ATP2B2 encodes the plasma membrane calcium pump PMCA2. We used immunohistochemistry in human cochlear sections to show that PMCA2 is located in the stereocilia of hair cells, suggesting its function in the auditory system is conserved between humans and mice. Although other genes in this region remain candidates, we conclude that haploinsufficiency of ATP2B2 is the most likely cause of SNHL in 3p-- syndrome.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 3/genetics , Hearing Loss, Bilateral/genetics , Hearing Loss, Sensorineural/genetics , Animals , Base Sequence , Child , Child, Preschool , Chromosome Mapping , Cochlea/metabolism , DNA Primers/genetics , Disease Models, Animal , Female , Hearing Loss, Bilateral/metabolism , Hearing Loss, Bilateral/physiopathology , Hearing Loss, Sensorineural/metabolism , Hearing Loss, Sensorineural/physiopathology , Humans , Immunohistochemistry , Male , Mice , Mutation , Plasma Membrane Calcium-Transporting ATPases/deficiency , Plasma Membrane Calcium-Transporting ATPases/genetics , Plasma Membrane Calcium-Transporting ATPases/metabolism , Species Specificity , Syndrome
6.
Zhonghua Er Bi Yan Hou Ke Za Zhi ; 26(6): 344-5, 382, 1991.
Article in Chinese | MEDLINE | ID: mdl-1725850

ABSTRACT

The calcium, magnesium and zinc ions in perilymph of the guinea pig were measured after hearing loss induced by gentamicin. The concentration of the calcium ions and magnesium ions increased, the zinc ions decreased in perilymph. The ototoxicity of gentamicin was related to the changes of these electrolytes in inner ear circumstance. The results showed that the changes of ions were the step of gentamicin ototoxicity.


Subject(s)
Gentamicins/adverse effects , Hearing Loss, Bilateral/metabolism , Perilymph/metabolism , Animals , Calcium/metabolism , Guinea Pigs , Hearing Loss, Bilateral/chemically induced , Ion Channels/drug effects , Magnesium/metabolism , Zinc/metabolism
7.
Eur J Clin Invest ; 20(4): 416-21, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2121501

ABSTRACT

Pseudohypoparathyroidism (PHP) is a rare disorder that might be caused by an hereditary defect in the G protein system. These membrane-bound proteins are responsible for the transduction of biological signals through the outer cell membrane. The investigation of 22 patients with PHP showed a symmetric sensorineural hearing loss in 63.6% of the subjects. In erythrocyte membrane preparations from blood samples of 15 of these patients, we measured the concentration of the stimulatory Gs protein and the inhibitory Gi protein by means of the Western blot analysis using selective antibodies against alpha-subunits of G proteins. In nine of the 15 cases (60%), we found a distinct decrease in the amount of the Gs protein with a partial preponderance of the Gi protein. These patients had a considerable symmetric sensorineural hearing loss. Pathophysiological mechanisms and the possible role of G proteins in the inner ear are discussed.


Subject(s)
GTP-Binding Proteins/deficiency , Hearing Loss, Bilateral/etiology , Pseudohypoparathyroidism/metabolism , Adolescent , Adult , Child , Female , Hearing Loss, Bilateral/metabolism , Humans , Male , Middle Aged , Pseudohypoparathyroidism/complications
8.
Am J Otol ; 10(1): 11-3, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2719084

ABSTRACT

The possible role of vitamin D in hearing impairment was investigated by the measurement of three metabolites of vitamin D in 28 patients with bilateral sensorineural hearing loss (BSNHL). Twenty-three of 28 patients showed a significantly decreased level of 1,25-dihydroxyvitamin D3, with a normal value of 25-hydroxyvitamin D3. In addition to experimental and clinical reports regarding vitamin D deficiency, the present study suggests that vitamin D deficiency is one of the etiologies of BSNHL, through the calcium metabolism and microcirculation in the cochlea.


Subject(s)
Hearing Loss, Sensorineural/metabolism , Vitamin D/metabolism , Adolescent , Adult , Aged , Calcifediol/blood , Calcitriol/blood , Calcium/metabolism , Child , Female , Hearing Loss, Bilateral/etiology , Hearing Loss, Bilateral/metabolism , Hearing Loss, Sensorineural/etiology , Humans , Male , Middle Aged , Vitamin D Deficiency/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...